medigraphic.com

2017, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (3)

Quality dimensions focused on the healthcare protocol Infarction Code (Código Infarto)

Arriaga-Dávila JJ, Pérez-Rodríguez G, Borrayo-Sánchez G

Language: Spanish
References: 24
Page: 382-387
PDF size: 386.79 Kb.


ABSTRACT

The Código Infarto (Infarction Code) strategy is part of the comprehensive care program “A Todo Corazón” (To All Heart), whose aim is to reinforce the prevention and health care of cardiovascular diseases. Mexico faces a big challenge, since it is the country with greater mortality secondary to acute myocardial infarction (AMI) in the first 30 days in patients of 45 years or older (28% compared with 7.9% of the average). In addition, Mexico’s population has a high prevalence of risk factors (hypertension, diabetes, tobacco use, dyslipidemias, overweight, and obesity). It is for these reasons that 18 months ago the Instituto Mexicano del Seguro Social (IMSS) implemented the first care protocol for patients with AMI, called Código Infarto, whose main aim is to guarantee the diagnosis and treatment of patients with AMI, so that they can receive, once they are admitted at IMSS emergency rooms, primary angioplasty in less than 90 minutes, or fibrinolytic therapy in less than 30 minutes. The quality focus in the Código Infarto strategy has six main dimensions: security, effectiveness, its focus on the patient, opportune, efficient, and [it offers] equitable [treatment]. The implementation of Código Infarto in IMSS is the first institutional strategy to face the leading cause of death in our country and it has produced up until now very encouraging results.


REFERENCES

  1. World Health Organization. WHO Mortality Database. Geneva, Switzerland: World Health Organization, Department of Health Statistics and Information Systems; 2015. http://www.who.int/healthinfo/ mortality_data/en/

  2. Instituto Nacional de Estadística y Geografía (INEGI). Estadísticas de mortalidad 2015. México: INEGI; 2015. Disponible en http://www.inegi.org.mx/est/ contenidos/proyectos/registros/vitales/mortalidad/ tabulados/ConsultaMortalidad.asp

  3. Organisation for Economic Co-operation and Development (OECD). OECD Health Statistics 2013. Paris: OECD; 2013. http://dx.doi.org/10.1787/health-data-en

  4. Organisation for Economic Co-operation and Development (OECD). OECD Health Statistics 2015. Paris: OECD; 2015. http://dx.doi.org/10.1787/health-data-en

  5. World Health Organization (OMS). Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, Switzerland: OMS; 2011.

  6. Secretaría de Salud. Dirección General de Información en Salud (DGIS). Base de datos de egresos hospitalarios por mortalidad en instituciones públicas, 2008-2013. Sistema Nacional de Información en Salud (SINAIS). México: Secretaría de Salud. Disponible en http://www.dgis.salud.gob.mx/ contenidos/basesdedatos/std_egresoshospitalarios. html

  7. Isordia-Salas I, Santiago-German D, Rodríguez- Navarro H, Almaraz-Delgado M, Leaños-Miranda A, Anaya-Gómez F, et al. Prevalence of Metabolic Syndrome Components in an Urban Mexican Sample: Comparison between Two Classifications. Exp Diabetes Res. 2012; 2012: 202540.

  8. Borrayo-Sánchez G, Madrid-Miller A, Arriaga-Nava R, Ramos-Corrales MA, García-Aguilar J, Almeida-Gutiérrez E. Riesgo estratificado de los síndromes coronarios agudos. Resultados del primer RENASCA-IMSS. Rev Med Inst Mex Seguro Soc. 2010;48(3):259-64.

  9. Programa Único Especializado de Preparación para el Examen Nacional de Aspirantes a Residencias Médicas (PUEP-ENARM). Liderazgo y experiencia médica. Publicado el 14 de julio de 2012. Disponible en https://issuu.com/liderazgoexperienciamedica/ docs/cardiologia/36

  10. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012 Oct; 33(20):2569-619.

  11. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29;127(4):e362-425.

  12. National Clinical Guideline Centre (UK). Myocardial Infarction with ST-Segment Elevation: The Acute Management of Myocardial Infarction with ST-Segment Elevation [Internet]. NICE Clinical Guidelines, No. 167. London: Royal College of Physicians (UK);2013 Jul.

  13. Berwick DM. A User’s Manual For The IOM’s. ‘Quality Chasm’ Report. Patients’ experiences should be the fundamental source of the definition of “quality.” Health Affairs. 2001;21(3):80-90.

  14. Bingham JW, Quinn DC, Richardson MG, Miles PV, Gabbe SG. Using a healthcare matrix to assess patient care in terms of aims for improvement and core competencies. Jt Comm J Qual Patient Saf. 2005 Feb;31(2):98-105.

  15. Normand ST, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. JAMA. 1996 May 1;275(17):1322-8.

  16. [No authors listed]. Measuring and improving quality of care: a report from the American Heart Association/ American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation. 2000;101: 1483-93.

  17. Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, Ingber MJ, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation. 2006 Apr 4;113 (13):1683-92.

  18. Ross JS, Maynard C, Krumholz HM, Sun H, Rumsfeld JS, Normand SL, et al. Use of administrative claims models to assess 30-day mortality among Veterans Health Administration hospitals. Med Care. 2010 Jul;48(7):652-8.

  19. Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, et al. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):34-59.

  20. Institute of Medicine (USA).Crossing the Quality Chasm. A New Health System for the 21st Century. Washington, DC: Institute of Medicine, National Academy Press; 2001.

  21. Schömig A, Ndrepepa G, Kastrati A. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur Heart J. 2006 Aug;27(16):1900-7.

  22. García-Castillo A, Jerjes-Sánchez C, Martínez Bermúdez P, Azpiri-López JR, Autrey-Caballero A, Martínez-Sánchez C et al. Registro Mexicano de Síndromes Coronarios Agudos (RENASICA II). Arch Mex Cardiol. 2005;75(Supl 1):S6-19.

  23. Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, López-Sendón J, Van de Werf F, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart. 2007 Feb;93(2):177-82.

  24. Regueiro A, Bosch J, Martín-Yuste V, Rosas A, Faixedas MT, Gómez-Hospital JA et al. Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network. BMJ Open. 2015;5(12): e009148.




2020     |     www.medigraphic.com